
    
      This is a randomized, double-blind, placebo-controlled, dosed tolerability, pharmacokinetic /
      pharmacodynamic study of a single oral SY-009 capsule for Chinese healthy subjects. Plan to
      screening no more than 64 healthy subjects ï¼Œ dividing them into 7 dose groups.
    
  